MENU
TNFA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TNF Pharmaceuticals (TNFA) Ownership - Who owns TNF Pharmaceuticals?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.82M
P/E Ratio
N/A
Total Cash
13.07M
Projected Growth
N/A
Total Debt
25.8K
Revenue
N/A
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash/Share
5.51
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TNFA
Capitalization
2.82M
P/E Ratio
N/A
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash
13.1M
Total Cash/Share
5.51
Total Debt
25.8K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-46.72K
P/B Ratio
0.44
Cash Flow
N/A
Earnings
-10.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.37K
Current Ratio
2.48
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-13.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-90.46
Shares Held By Institutions
116K
Shares Outstanding - Current
2.37M
Total Liabilities
26M
Total Volume MTD
N/A
Value
1
Gain YTD
360.572
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information